MimoPools™

The latest innovation from the experts in PepSets™ Peptide Library synthesis, MimoPools are uniquely suited to cutting-edge research applications.


These modern peptide libraries are aliquoted and pooled into one convenient peptide mix for maximum manouvereability.

Expanded Applications

MimoPools™ takes standard peptide library screening studies further with critical applications in antigen-specific T-cell response studies, epitope mapping, and immune monitoring.


Pivotal in the continuing worldwide SARS-CoV-2 research, strategically synthesised peptide pools can contain specific sequences for mutations in key proteins or complete protein sequences for each variant.

High Quality Peptides

MimoPools™ are produced using the same validated peptide library synthesis procedures we’re known for. Our stringent quality control measures guarantee identity and purity, and all peptide pools are supplied with a Certificate of Analysis and Mass Spectrometry data. 


Designed For Success

MimoPools™ are expertly designed on a case-by-case basis to include pre-synthesised catalogue peptides or made-to-order sequences, with all of the modification and customisation option typical of a standard peptide library.


The design of truncated peptide pool has been optimised for T-cell studies by the inclusion of four strategically truncated lengths of the same sequence in each pool.

MimoPools™ are available as-synthesised or purified up to 95%. These peptide pools are supplied as freeze-dried aliquots, offering long-term stability, and allowing MimoPools™ to be used and reused at your convenience.

Contact us today for a quote! 

Australia

☎ +61 3 9565 1111

✉ australia@mimotopes.com

North and South America 

☎ +1 651 603 0909

✉ useast@mimotopes.com

✉ uswest@mimotopes.com



asia

☎ +61 3 9565 1111

✉ asia@mimotopes.com


UK / Europe / Africa / Middle East

☎ +44 (0)151 556 0547

✉ europe@mimotopes.com

Contact us today for a quote! 

Australia

☎ +61 3 9565 1111

australia@mimotopes.com

North and South America 

☎ +1 651 603 0909

  ✉ useast@mimotopes.com 
  ✉ uswest@mimotopes.com

asia

☎ +61 3 9565 1111

✉ asia@mimotopes.com

UK/ Europe/ Africa/ Middle East

☎ +44 (0)151 556 0547

✉ europe@mimotopes.com

Go to article: Home | Are metaverse applications becoming a reality in medical training?Go to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: BriefingGo to article: Industry newsGo to article: The medical industry briefingGo to article: Alleima Company InsightGo to article: AlleimaGo to article: Thermo Fisher Scientific Company InsightGo to article: Thermo Fisher ScientificGo to article: MimotopesGo to article: CommentGo to article: 22 million US health records breached thus far in 2022Go to article: VR and AR are maturing as medical training tools, but what about mixed reality?Go to article: Augmented reality for orthopaedic surgery assistanceGo to article: mdi ConsultantsGo to article: SartoriusGo to article: WatlowGo to article: Mecmesin Company InsightGo to article: MecmesinGo to article: In DepthGo to article: Are metaverse applications becoming a reality in medical training?Go to article: Microneedle tech: 3D printing to the rescueGo to article: Why aren’t digital pills taking off?Go to article: Connected devices: a tsunami of clinical trial dataGo to article: Apple RubberGo to article: AccumoldGo to article: Tricor SystemsGo to article: In DataGo to article: Medical device companies best positioned to weather industry disruptionGo to article: Medical industry found it easier to fill vacancies in Q2 2022Go to article: AI innovation in medical industry dropped in the three months ending JuneGo to article: MelexisGo to article: TS Quality & EngineeringGo to article: EventsGo to article: Next Issue